Advertisement

Topics

Knopp Biosciences Announces Publication of Eosinophil-Lowering Effects of Dexpramipexole in Multiple Clinical Trials

06:00 EST 7 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Knopp Biosciences LLC today announced the publication of results from multiple clinical trials demonstrating the eosinophil-lowering effects of dexpramipexole, a small molecule treatment in development for eosinophil-associated ...

Other Sources for this Article

Knopp Biosciences LLC
Tom Petzinger, +1-412-488-1776
tom@knoppbio.com

NEXT ARTICLE

More From BioPortfolio on "Knopp Biosciences Announces Publication of Eosinophil-Lowering Effects of Dexpramipexole in Multiple Clinical Trials"

Advertisement
Quick Search
Advertisement
Advertisement